Diclofenac predisposes benign prostate hyperplasia in fat feed albino rats
dc.contributor.author | Zaruwa, M.Z. | |
dc.contributor.author | Abdullahi, Halima Sadiya | |
dc.contributor.author | Muhammad, Yusuf Bawa | |
dc.contributor.author | Muhammad, Abdullahi Ubana | |
dc.contributor.author | Bamidele, Titilayo Oluwayemisi | |
dc.contributor.author | Muhammad, Ruqaiyatu Muhammad | |
dc.contributor.author | Ubaoji, K.I. | |
dc.date.accessioned | 2023-12-14T06:38:13Z | |
dc.date.available | 2023-12-14T06:38:13Z | |
dc.date.issued | 2022-01-10 | |
dc.description.abstract | Background: An attempt to establish the possible cause(s) of benign prostate hyperplasia (BPH) in fat feed albino rats treated with diclofenac (DCF)-potassium (K) was performed to ascertain its likely translational relationship in humans. Methods: Thirty-five male wistar albino rats of 24 weeks old were divided into five groups of 7 animals each were used. Group 1; the normal control (NC) was injected subcutaneously with the vehicle (olive oil) only and served normal diet. Group 2; standard group treated with testosterone propionate in olive oil (3 mg/kg b. wt.). Groups 3, 4, and 5 were fed with the standard feed mixed with animal fat (sourced from roasted meat/condiments in aluminium foils) in 20, 40 and 80% portions, then treated with DCF-K in solution as low (2 mg/kg b. wt.), mid (4 mg/kg b. wt.), and high (6 mg/kg b. wt.) doses, respectively. The blood samples collected were analysed for prostate specific antigen (PSA), hematological parameters, kidney and liver function. Results: Group 3 showed the highest PSA elevation (p<0.05) when compared to the control and the untreated group. There was a significant elevation (p<0.05) in WBC levels compared to all other groups. PCV, MCV, NEUT, MONO and EOSIN levels increased significantly (p<0.05) across all groups. Significant (p<0.05) increase was observed in liver and kidney parameters compared to the untreated groups. Significant (p<0.05) elevation in total cholesterol and LDL- C levels across the groups was observed. The DCF-K treated groups showed increase in several parameters compared to the untreated groups. Conclusions: It was obvious that fatty diet and use of DCF-K contributed to the observed hepatotoxicity, nephrotoxicity, hence predisposed tissue damage and inflammation which conjunctly elevated PSA. | en_US |
dc.identifier.citation | Muhammad, A.U. et. al. (2022). Diclofenac predisposes benign prostate hyperplasia in fat feed albino rats | en_US |
dc.identifier.uri | https://keffi.nsuk.edu.ng/handle/20.500.14448/5422 | |
dc.language.iso | en | en_US |
dc.publisher | Department of Biochemistry and Molecular Biology, Nasarawa State University Keffi | en_US |
dc.subject | Diclofenac, Fat, Hepatotoxicity, Haematology, PSA | en_US |
dc.title | Diclofenac predisposes benign prostate hyperplasia in fat feed albino rats | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 14. Diclofenac predisposes benign prostate hyperplasia in fat feed albino.pdf
- Size:
- 158.58 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
License bundle
1 - 1 of 1